Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC Rule changes

"As I've been saying for many years, there will come a time when PTSC will need a change of directors, and at that time, I will be calling for "new talent" just as voiciferously as all. But I will not support any nomination based solely on their shareholding."

But many shareholders (at least here at Agora) want a change now because they want the shareprice to increase now because they want to sell then.

That's by the way the biggest paradox with all this "increase my shareholder value" yelling:
IMO people are not really interested in a substantial shareholder value, they simply want to sell their shares in order to break even or take profits.
Not that I have a problem with that - that's why we're all here: selling with a great profit!

The question is: Who of us "Agoras &Cie" will still be PTSC shareholder if PTSC should ever be a "mature" company? Wouldn't it be realistic to assume that 99% of us will sell asap if their personal "best price" has been reached?

Of course all of this is hypothetical as long PTSC is in the pennies.

We'll see what the next days and weeks will bring - glta

Share
New Message
Please login to post a reply